Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
More Reading from MarketBeat Media The 3 Penny Stocks You Swore You'd Never Buy (But You'll Check Anyway)Reported by Chris Markoch. Date Posted: 1/18/2026. 
In Brief - Vaxart is a clinical-stage biotech developing oral vaccines that could transform global immunization if its platform proves effective.
- Microvision develops cost-effective lidar technology for autonomous vehicles, with upside tied to industry adoption and potential partnerships.
- Datavault AI focuses on monetizing digital data through AI and blockchain tools, offering speculative exposure to the emerging data-as-an-asset theme.
Penny stocks attract speculative investors seeking high-risk, high-reward opportunities. Investors often target companies with disruptive technologies, exposure to emerging trends, or compelling turnaround stories. Many of these firms won’t survive or scale, but if one succeeds, returns can be substantial. For investors who believe strength lies in numbers, MarketBeat offers a tool that lists the 100 Most Popular Penny Stocks, ranked by the number of MarketBeat subscribers following each company. While popularity isn’t a guarantee of success, it can give investors added conviction. A freight train pulling 50 railcars can be worth $2 million in economic value. That's the idea behind a new trading concept called the Money Train Method. Imagine bumping your win rate from 50 percent up to 60, 75, or even 80 percent while increasing each trade's profit potential to an average gain of 20 to 30 percent, with triple-digit runners possible. The strategy also builds in downside protection with a reward-to-risk ratio of 1.2 to 1. See how the Money Train Method works. Some investors define a penny stock as any share trading at $5 or less, but this screener uses the traditional definition—stocks priced below $1. These names are highly volatile; conduct your own research and make sure any position fits your risk tolerance before investing. Vaxart: A Potential Game-Changer for Global Immunization Efforts Vaxart Inc. (NASDAQ: VXRT) is a clinical-stage biotechnology company developing oral vaccines for infectious diseases including influenza, norovirus, and COVID-19. Unlike traditional injected vaccines, Vaxart’s tablet-based platform aims to simplify distribution and improve global accessibility. The bull case centers on that innovative delivery approach. If Vaxart obtains FDA approval and can scale production, its oral vaccines could lower logistical barriers to mass immunization and create meaningful licensing opportunities. Positive trial results or a commercial collaboration could materially shift sentiment and valuation from the stock’s current low base. Clinical risk remains the primary challenge. Vaxart has not yet brought a product to market, and vaccine development is costly and unpredictable. Competition from established players with larger R&D budgets also clouds visibility into commercial prospects. For now, VXRT is a long-term speculative bet on platform validation rather than near-term profitability. MarketBeat analyst ratings show just one analyst covering Vaxart, and institutional ownership is only about 18%, both of which increase informational and market risk. On the positive side, short interest is roughly 2%, which may temper some near-term volatility. Microvision: Developing Cost-Effective LiDAR Units For Autonomous Driving Microvision Inc. (NASDAQ: MVIS) develops LiDAR (light detection and ranging) sensors used in autonomous vehicles, smart infrastructure, and industrial sensing. Its hardware and software enable precise 3D mapping needed for self-driving systems and advanced driver-assistance (ADAS). Microvision focuses on compact, cost-effective LiDAR units that could appeal to automakers seeking scalable sensor solutions. The bull case rests on the continued push toward vehicle automation and the potential to secure partnerships with major automakers. If Microvision can demonstrate performance or cost advantages, it could land supply agreements or licensing deals that improve revenue visibility. The technology also has applications in robotics and smart-city infrastructure, which adds optionality to the growth story. That said, Microvision faces stiff competition from LiDAR players like Luminar (NASDAQ: LAZR), Innoviz (NASDAQ: INVZ), and Ouster (NYSE: OUST). The path to profitability is uncertain, and repeated delays in commercial adoption of LiDAR technology have frustrated investors. MVIS is covered by three analysts and carries a consensus price target of $2.50, roughly a 169% premium to its Jan. 15 close. Still, institutional ownership remains relatively low (around 30%), while short interest is elevated (about 21%), signaling that investors should expect high volatility. Datavault AI: Trying to Democratize Data Ownership Datavault AI Inc. (NASDAQ: DVLT) operates at the intersection of artificial intelligence, data monetization, and digital-asset management. The company helps organizations turn raw data into tradable, revenue-generating assets through its patented Datavault platform. By combining AI, blockchain, and analytics, Datavault AI aims to democratize data ownership and unlock monetization opportunities that traditional systems overlook. The bullish thesis centers on a niche focus and scalability potential. As data becomes an increasingly valuable commodity, businesses—and potentially individuals—are seeking secure ways to monetize digital information. Datavault’s technology could benefit from broader AI adoption and growing attention to data sovereignty. Early-stage traction or strategic partnerships could catalyze investor confidence. Still, Datavault AI operates in a highly experimental space. Its business model is evolving, and the path to meaningful revenue growth is unproven. Institutional ownership is below 1%, and short interest exceeds 16% at the time of writing. Investors considering DVLT should view it as a long-term, speculative position based on belief in the data-as-an-asset thesis rather than near-term earnings potential.
| 
